Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.43 USD | -1.23% | +1.58% | -26.68% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.